HUP9602204D0 - Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells - Google Patents

Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells

Info

Publication number
HUP9602204D0
HUP9602204D0 HU9602204A HUP9602204A HUP9602204D0 HU P9602204 D0 HUP9602204 D0 HU P9602204D0 HU 9602204 A HU9602204 A HU 9602204A HU P9602204 A HUP9602204 A HU P9602204A HU P9602204 D0 HUP9602204 D0 HU P9602204D0
Authority
HU
Hungary
Prior art keywords
disfunction
pharmaceutical compositions
endothelial cells
vascular endothelial
treating diseases
Prior art date
Application number
HU9602204A
Other languages
Hungarian (hu)
Inventor
Andrea Jendakovits
Laszlo Ueroegdi
Ede Marvanyos
Mihaly Barabas
Istvan Kurucz
Ernoe Bacsy
Gyoergy Dorman
Sandor Erdoe
Laszlo Koranyi
Gyoergy Schmidt
Marta Sinka
Marta Vitai
Original Assignee
Biorex Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Rt filed Critical Biorex Rt
Priority to HU9602204A priority Critical patent/HUP9602204D0/en
Publication of HUP9602204D0 publication Critical patent/HUP9602204D0/en
Priority to UA99020697A priority patent/UA64716C2/en
Priority to IL12825697A priority patent/IL128256A/en
Priority to HK00103903.0A priority patent/HK1025506B/en
Priority to DE69736130T priority patent/DE69736130T2/en
Priority to EEP199900044A priority patent/EE04044B1/en
Priority to CA002262997A priority patent/CA2262997C/en
Priority to PT97933813T priority patent/PT966283E/en
Priority to PCT/HU1997/000044 priority patent/WO1998006400A2/en
Priority to US09/230,941 priority patent/US6143741A/en
Priority to JP50952798A priority patent/JP2001504446A/en
Priority to RU99104809/14A priority patent/RU2195273C2/en
Priority to DK97933813T priority patent/DK0966283T3/en
Priority to AT97933813T priority patent/ATE329592T1/en
Priority to SK154-99A priority patent/SK284301B6/en
Priority to SI9730739T priority patent/SI0966283T1/en
Priority to EP97933813A priority patent/EP0966283B1/en
Priority to YUP-51/99A priority patent/RS49719B/en
Priority to HRP9602204A priority patent/HRP970433A2/en
Priority to AU37049/97A priority patent/AU739614B2/en
Priority to ES97933813T priority patent/ES2267148T3/en
Priority to PL97331601A priority patent/PL190673B1/en
Priority to CZ0043599A priority patent/CZ298542B6/en
Priority to NO19990547A priority patent/NO325109B1/en
Priority to BG103194A priority patent/BG64456B1/en

Links

HU9602204A 1996-08-09 1996-08-09 Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells HUP9602204D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
HU9602204A HUP9602204D0 (en) 1996-08-09 1996-08-09 Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells
UA99020697A UA64716C2 (en) 1996-08-09 1997-06-08 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
CZ0043599A CZ298542B6 (en) 1996-08-09 1997-08-06 Use of hydroxylamine derivatives for preparing a medicament for treating and prevention of diseases connected with dysfunction of vascular endothelial cells and pharmaceutical composition containing thereof
JP50952798A JP2001504446A (en) 1996-08-09 1997-08-06 Drugs for treating and preventing diseases arising from vascular endothelial cell damage
AT97933813T ATE329592T1 (en) 1996-08-09 1997-08-06 PHARMACEUTICAL PRODUCTS FOR THE CURE AND PREVENTION OF DISEASES ARISING FROM DAMAGE TO VASCULAR ENDOTHELIAL CELLS
DE69736130T DE69736130T2 (en) 1996-08-09 1997-08-06 PHARMACEUTICAL PRODUCTS FOR THE HEALING AND PREVENTION OF DISEASES ARISING FROM THE DAMAGE TO THE VASCULAR ENDOTHELIAL CELLS
EEP199900044A EE04044B1 (en) 1996-08-09 1997-08-06 Pharmaceutical products for the treatment and prevention of diseases caused by vascular endothelial cell damage
CA002262997A CA2262997C (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
PT97933813T PT966283E (en) 1996-08-09 1997-08-06 PHARMACEUTICAL PRODUCTS FOR THE CURE AND PREVENTION OF DISEASES RESULTING FROM LESION OF VASCULAR ENDOTHELIUM CELLS
PCT/HU1997/000044 WO1998006400A2 (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
US09/230,941 US6143741A (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
IL12825697A IL128256A (en) 1996-08-09 1997-08-06 Use of hydroxylamine derivatives in the preparation of pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells and pharmaceutical compositions
RU99104809/14A RU2195273C2 (en) 1996-08-09 1997-08-06 Pharmaceutical compounds for treatment and prophylaxis of diseases arising as result of damage of vascular endothelial cells
DK97933813T DK0966283T3 (en) 1996-08-09 1997-08-06 Pharmaceuticals for the healing and prevention of diseases resulting from damage to vascular endothelial cells
HK00103903.0A HK1025506B (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells
SK154-99A SK284301B6 (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
SI9730739T SI0966283T1 (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells
EP97933813A EP0966283B1 (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells
YUP-51/99A RS49719B (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells
HRP9602204A HRP970433A2 (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells
AU37049/97A AU739614B2 (en) 1996-08-09 1997-08-06 Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells
ES97933813T ES2267148T3 (en) 1996-08-09 1997-08-06 PHARMACEUTICAL PRODUCTS TO CURE AND PREVENT THE RESULTS OF THE DAMAGE OF VASCULAR ENDOTELIAL CELLS.
PL97331601A PL190673B1 (en) 1996-08-09 1997-08-06 Application of hydroxylamine derivatives
NO19990547A NO325109B1 (en) 1996-08-09 1999-02-05 Use of hydroxylamine derivatives for the manufacture of medicaments for the treatment of diseases caused by damage to endothelial cells
BG103194A BG64456B1 (en) 1996-08-09 1999-02-22 Pharmaceutical products for the treatment and prevention of diseases caused by the impairment of the vascular endothelial cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9602204A HUP9602204D0 (en) 1996-08-09 1996-08-09 Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells

Publications (1)

Publication Number Publication Date
HUP9602204D0 true HUP9602204D0 (en) 1996-10-28

Family

ID=90014237

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9602204A HUP9602204D0 (en) 1996-08-09 1996-08-09 Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells

Country Status (3)

Country Link
HR (1) HRP970433A2 (en)
HU (1) HUP9602204D0 (en)
RU (1) RU2195273C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2271202C1 (en) * 2005-05-04 2006-03-10 Михаил Владимирович Покровский Method for correcting endothelial dysfunction
RU2338520C1 (en) * 2007-02-28 2008-11-20 Илья Николаевич Медведев Method of correction of nitrogen oxide level in blood of patients with metabolic syndrome
RU2425672C1 (en) * 2010-04-12 2011-08-10 Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Method of correcting hyperhomocystein-induced endothelial dysfunction by mixture of solutions of homeopathic dilutions of polyclonal rabbit antibodies to human endothelial nitrogen oxide synthase- c12, c30, c200
MD4412C1 (en) * 2014-08-29 2016-11-30 Алёна ДУРНЯ Use of 4-({2-butyl-5-[2-carboxy-2-(thiophene-2-ylmethyl)et-1-en-1-yl]-1H-imidazole-1-yl}methyl)benzoic acid to improve vascular elasticity in the prevention of complications of hypertensive genesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177578B (en) * 1976-08-27 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
RU2083567C1 (en) * 1991-04-25 1997-07-10 Ф.Хоффманн-Ля Рош Аг Derivatives of arylsulfoneamide or their salts and pharmaceutical composition showing antiprotective, antihypertension and vasospamolytic, in part, antiischemic action
RO115873B1 (en) * 1994-05-06 2000-07-28 Biorex Kutato Es Fejleszto Rt. Hydroximic acid derivatives, processes for preparing the same, intermediates for carrying out one of the processes and pharmaceutical composition

Also Published As

Publication number Publication date
RU2195273C2 (en) 2002-12-27
HRP970433A2 (en) 1998-08-31

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
FI962154L (en) Composition for the in vivo preparation of therapeutic products
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
SI0730864T1 (en) Medicament for treating cardiac inflammatory diseases
ZA983451B (en) Substituted imidazoles useful in the treatment of inflammatory diseases.
AU2027595A (en) Pharmaceutical composition for treating inflammatory bowel diseases
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
ZA984174B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
IL133089A0 (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
GB9517043D0 (en) The use of bile acid derivatives
EP0855387A4 (en) 2-acylaminobenzamide derivatives and preventive and remedy for diseases caused by the supermultiplication of vascular intimal cells
HUP9901247A3 (en) Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency
HUP9602204D0 (en) Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells
HUP9904173A3 (en) Pharmaceutical composition for treating viral diseases
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
ZA929879B (en) Compositions for the treatment of mammalian diseases.
IL129623A0 (en) Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
AU2754997A (en) The treatment of plant diseases
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
AUPO922297A0 (en) Disulphide useful in the treatment of cardiovascular diseases